Secondary data sourced from routinely collected healthcare information is playing a decisive role in stakeholder decision making. Join us to learn how this data is accessed today, which database is right for your purposes, and the key steps you need to consider to optimize your studies from planning to execution. Discover more about:

• Identifying the typical research questions across the drug lifecycle
• Understanding what secondary data sources are fit for which purpose
• Accessing clinically rich secondary data in rare diseases and oncology through novel solutions
• Generating the right evidence for regulators, payers, providers, and patients

We will share tangible examples of how multi-country database studies leveraging secondary data have helped answer key stakeholder questions throughout the product lifecycle.